EDSA — Edesa Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- $12.50m
- $10.97m
Annual cashflow statement for Edesa Biotech, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.3 | -17.5 | -8.37 | -6.17 | -7.19 |
| Depreciation | |||||
| Non-Cash Items | 3.2 | 2.26 | 1.25 | 0.523 | 0.73 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.64 | 2.89 | 0.308 | 0.571 | -0.986 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -13.7 | -12.3 | -6.64 | -4.89 | -7.32 |
| Capital Expenditures | -0.006 | -0.006 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.006 | -0.006 | 0 | — | — |
| Financing Cash Flow Items | -0.188 | -0.328 | -0.285 | -0.108 | -0.352 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.2 | 11.6 | 4.83 | 0.592 | 17 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.626 | -0.748 | -1.73 | -4.32 | 9.75 |